Ahmed A. Elhadidy, A. Selim, M. Sarhan, M. Mabrouk, Heba Samier, A. Elsawy
{"title":"肝细胞癌根治性消融术后丙型肝炎直接抗病毒药物的最佳起始时间提高肿瘤无复发生存率","authors":"Ahmed A. Elhadidy, A. Selim, M. Sarhan, M. Mabrouk, Heba Samier, A. Elsawy","doi":"10.21608/jcbr.2021.64062.1182","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":428417,"journal":{"name":"International Journal of Cancer and Biomedical Research","volume":"80 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Optimum initiation-time of direct-acting antivirals for hepatitis C after curative ablation of hepatocellular carcinoma improves neoplastic recurrence-free survival\",\"authors\":\"Ahmed A. Elhadidy, A. Selim, M. Sarhan, M. Mabrouk, Heba Samier, A. Elsawy\",\"doi\":\"10.21608/jcbr.2021.64062.1182\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":428417,\"journal\":{\"name\":\"International Journal of Cancer and Biomedical Research\",\"volume\":\"80 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Cancer and Biomedical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21608/jcbr.2021.64062.1182\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer and Biomedical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/jcbr.2021.64062.1182","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Optimum initiation-time of direct-acting antivirals for hepatitis C after curative ablation of hepatocellular carcinoma improves neoplastic recurrence-free survival